Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
1.10.3 Objective - 3
1.10.4 Objective - 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Peri-Implantitis Market: Variables, Trends, & Scope
3.1 Market Segmentation And Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Increasing Number Of Patients Having Dental Implants And A History Of Periodontitis
3.2.2.1 Advent Of Technological Advancements Pertaining To Dental Procedure
3.2.2.2 Rise In Behavioral Risk Factors Like Smoking And Diabetes
3.2.3 Market Restraint Analysis
3.2.3.1 High Cost Of Surgical Treatment
3.3 Penetration & Growth Prospect Mapping
3.4 Peri-Implantitis: Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.2 PESTEL Analysis
Chapter 4 Peri-Implantitis Market: Method Type Segment Analysis
4.1 Peri-Implantitis: Method Type Market Share Analysis, 2019 & 2027
4.2 Surgical
4.2.1 Surgical Method market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.2.2 Bone Regeneration
4.2.2.1 Bone Regeneration Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.2.3 Open Flap Debridement
4.2.3.1 Open Flap Debridement Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.2.4 Implantoplasty
4.2.4.1 Implantoplasty Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3 Non-Surgical
4.3.1 Non-Surgical Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.2 Mechanical Debridement
4.3.2.1 mechanical Debridement Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.3 Laser Debridement
4.3.3.1laser Debridement Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.4 Antibiotics
4.3.4.1 antibiotics Market Estimates And Forecasts, 2016 - 2027 (USD Million)
4.3.5 Others
4.3.5.1 others Market Estimates And Forecasts, 2016 - 2027 (USD Million)
Chapter 5 Peri-Implantitis Market: Regional Analysis
5.1 Peri-Implantitis: Regional Market Share Analysis, 2019 & 2027
5.2 North America
5.2.1 North America Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3 Europe
5.3.1 Europe Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.2 U.K.
5.3.2.1 U.K. Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.3 Germany
5.3.3.1 Germany Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.4 France
5.3.4.1 France Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.5 Italy
5.3.5.1 Italy Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.3.6 Spain
5.3.6.1 Spain Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.2 China
5.4.2.1 China Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.3 India
5.4.3.1 India Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.4 Japan
5.4.4.1 Japan Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.4.5 South Korea
5.4.5.1 South Korea Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5 Latin America
5.5.1 Latin America Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.5.4 Argentina
5.5.4.1 Argentina Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6 MEA
5.6.1 MEA Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6.3 Saudi Arabia
5.6.3.1 Saudi Arabia Peri-Implantitis Market, 2016 - 2027 (USD Million)
5.6.4 UAE
5.6.4.1 UAE Peri-Implantitis Market, 2016 - 2027 (USD Million)
Chapter 6 Company Profiles
6.1 Pfizer Inc.,
6.1.1.1 Company Overview
6.1.1.2 Financial Performance
6.1.1.3 Product Benchmarking
6.1.1.4 Strategic Initiatives
6.2 Cadila Pharmaceuticals
6.1.2.1 Company Overview
6.1.2.2 Financial Performance
6.1.2.3 Product Benchmarking
6.1.2.4 Strategic Initiatives
6.3 R.N. Laboratories Pvt. Ltd.
6.1.3.1 Company Overview
6.1.3.2 Financial Performance
6.1.3.3 Product Benchmarking
6.1.3.4 Strategic Initiatives
6.4 Basic Pharma Life Science Pvt. Ltd
6.1.4.1Company Overview
6.1.4.2 Financial Performance
6.1.4.3 Strategic Initiatives
6.5 Prachi Pharmaceuticals Private Limited
6.1.5.1Company Overview
6.1.5.2 Financial Performance
6.1.5.3 Product Benchmarking
6.1.5.4 Strategic Initiatives
6.6 Geistlich Pharma Inc.
6.1.6.1Company Overview
6.1.6.2 Financial Performance
6.1.6.3 Product Benchmarking
6.1.6.4 Strategic Initiatives
6.7 Healthy Life Pharma
6.1.7.1 Company Overview
6.1.7.2 Financial Performance
6.1.7.3 Product Benchmarking
6.1.7.4 Strategic Initiatives



List of Tables



Table 1 List of secondary sources
Table 2 List of Abbreviation